close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

16.61 +0.25 (+1.56%)
Delayed Quote Updated: 12:56 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday ↗
A $250 mixed shelf offering isn't sitting well with the biotech's shareholders. 
Via The Motley Fool
News headline image
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? ↗
It could be. 
Via The Motley Fool
News headline image
What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗
Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ: 
Via Benzinga
News headline image
Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript ↗
AUPH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals ↗
The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on. 
Via The Motley Fool
News headline image
Aurinia Pharmaceuticals: Q3 Earnings Insights ↗
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the... 
Via Benzinga
News headline image
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
No Negative Reaction ↗
Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗
Upgrades For Boot Barn Holdings Inc (NYSE: 
Via Benzinga
News headline image
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Cyber Currency ↗
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
Via Talk Markets
News headline image
Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass? ↗
Aurinia stock hit another record Monday on Bristol's rumored takeover. 
Via Investor's Business Daily
News headline image
55 Biggest Movers From Friday ↗
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World... 
Via Benzinga
News headline image
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today ↗
The biotech is reportedly in buyout talks with Bristol Myers Squibb. 
Via The Motley Fool
News headline image
Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover ↗
Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted. 
Via Investor's Business Daily
News headline image
More Chinese Trouble ↗
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
News headline image
A Bit Of A Recovery ↗
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week. 
Via Talk Markets
News headline image
Pharma, Tech and Finance ↗
Good news on some drugs was not enough to boost stock markets. 
Via Talk Markets
News headline image
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... 
Via Benzinga
News headline image
Sunday Special ↗
I have a taste for nuclear electricity which France pioneered decades ago, building power stations along the Loire Valley and in other regions. So I took my taste for uranium into my US holdings. 
Via Talk Markets
Topics Energy
News headline image
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
Post-Rosh Hashanah, Sell? ↗
As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year? 
Via Talk Markets
News headline image
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Aurinia Pharmaceuticals finalizes acquisition agreement with Leading Pharma Giant
Via Get News
News headline image
Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock ↗
Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.